WELLESLEY, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Technological advancements, the aging populations of ...
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing ...
First clinical trial of CAR-T NKR-2 cell therapy completed with encouraging safety profile and ...
